Red X iconGreen tick iconYellow tick icon

image alt textResearch Associate Professor

BSc(Hons) PhD(Otago)

Email anna.pilbrow@otago.ac.nz

Christchurch Heart Institute
Department of Medicine
University of Otago, Christchurch
PO Box 4345
Christchurch
New Zealand

Current roles

  • Leader of the Omics Laboratory, Christchurch Heart Institute
  • Deputy Head of Department, Medicine

Research interests

Cardiovascular Genetics

Anna completed her PhD at the University of Otago, Christchurch in 2006 and undertook postdoctoral training at the Salk Institute, La Jolla, California, USA from 2008–2010.

Since returning to Aotearoa in 2010, her research has focussed on understanding the mechanisms underlying our inherited susceptibility to heart disease. She has a particular interest in identifying molecules circulating in our blood that may signal the early stages of heart disease and contribute to a poor prognosis in heart patients.

Anna is currently leading a large international study to identify genetic variants that may influence progression from coronary artery disease to heart failure.

Awards

  • University of Otago Christchurch Four Year Fellowship, 2023
  • Heart Foundation of New Zealand Foundation100 Fellowship, 2021
  • Finalist, Division of Health Sciences, Otago University Students’ Association Supervisor of the Year Award, 2020
  • ThermoFisher Scientific Award for Excellence in Molecular Biology, Queenstown Research Week, 2017
  • Heart Foundation of New Zealand Senior Fellowship, 2014
  • University of Otago Early Career Award for Distinction in Research, 2014
  • Sir Charles Hercus Health Research Fellowship, 2011

Affiliations

  • Department of Medicine
  • Christchurch Heart Institute

Publications

Gibbs, S. F. P., Jones, G. T., Cameron, V. A., Fakahau, T., Frampton, C., Earle, N. J., Poppe, K. K., … Troughton, R., Pilbrow, A. P., & Faatoese, A. F. (2024). Associations between DNA methylation and cigarette smoking in Pacific Peoples living in Aotearoa New Zealand. Proceedings of the 17th GeneMappers Conference. Retrieved from https://www.genemappersconference.org Conference Contribution - Published proceedings: Abstract

Ocariza, M. G. C., Paton, L. N., Tang, W. H. W., Templeton, E. M., Pilbrow, A. P., Pemberton, C. J., & Appleby, S. (2024). CNDP2 is a potential modulator of heart failure outcomes. Proceedings of the 17th GeneMappers Conference. Retrieved from https://www.genemappersconference.org Conference Contribution - Published proceedings: Abstract

Deane, A., Myall, D., Pilbrow, A., Shoorangiz, R., Sharifzadeh-Kermani, A., Anderson, T., Dalrymple-Alford, J., … Melzer, T. (2024). Neurovascular involvement in Parkinson's disease (PD) cognitive impairment: A 4D flow study. Movement Disorders, 39(Suppl. 1), (pp. S480). doi: 10.1002/mds.29953 Conference Contribution - Published proceedings: Abstract

Paterson, M. A., Pilbrow, A. P., Frampton, C. M. A., Cameron, V. A., Troughton, R. W., Pemberton, C. J., … Richards, A. M., … Palmer, B. R. (2024). Plasma soluble fms-like tyrosine kinase-1, placental growth factor, and vascular endothelial growth factor system gene variants as predictors of survival in heart failure. European Journal of Heart Failure. Advance online publication. doi: 10.1002/ejhf.3368 Journal - Research Article

Earle, N., Pilbrow, A., Poppe, K., Choi, Y., Logue, G., Devlin, G., … Richards, M., … Troughton, R., Cameron, V., … Doughty, R. (2024). Pharmacogenomic variation in antiplatelet and anticoagulant medication response: Data from the Multi-Ethnic New Zealand Study of Acute Coronary Syndromes. Heart, Lung & Circulation, 33(Suppl. 2), (pp. S71). doi: 10.1016/j.hlc.2024.04.248 Conference Contribution - Published proceedings: Abstract

Back to top